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228 Copyright © 2017 John Wiley & Sons, LtdIn this paper, we describe the use of Cu‐mediated [18F]fluorodeboronation for
the automated production of positron emission tomography radiotracers suit-
able for clinical use. Two recurrent issues with the method, low radiochemical
conversion on automation and protoarene byproduct purification issues, have
been successfully addressed. The new method was utilized to produce sterile
injectable doses of [18F]‐(±)‐IPMICF17, a positron emission tomography radio-
tracer for tropomyosin receptor kinase B/C, using an automated synthesis mod-
ule. The product was isolated in 1.9 ± 0.1% isolated radiochemical yield,
excellent radiochemical purity (>99%), and high specific activity
(5294 ± 1227 Ci/mmol). Quality control testing confirmed that doses were suit-
able for clinical use.
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radiochemistry1 | INTRODUCTION
The use of arylboron compounds as precursors for
radiofluorination has increased the scope of late‐stage
radiofluorination to include electron neutral and rich
arenes (and related substrates).1,2 This, in turn, hasnen on the occasion of his
. wileyonlinelibrarincreased the number of accessible scaffolds that can be
radiofluorinated to generate radiotracers for use in func-
tional positron emission tomography (PET) imaging.
Based on pioneering work conducted by the Sanford
lab,3 our recent report demonstrated that the copper‐
mediated nucleophilic radiofluorination of arylboron spe-
cies, including boronic acids, pinacol boronate esters, and
BF3 salts, can be achieved in good radiochemical conver-
sion (RCC; % of integrated area corresponding to productJ Label Compd Radiopharm. 2018;61:228–236.y.com/journal/jlcr
MOSSINE ET AL. 229versus total radioactivity in a radio‐thin layer chromatog-
raphy [TLC] trace).2 The reaction utilizes a small quantity
of aryl boron precursor (4 μmol), which facilitates adap-
tion of the chemistry for automation and purification by
semipreparative HPLC and solid phase extraction. Subse-
quently, we and others have also optimized this chemistry
further, including exploring substrate scope, functional
group tolerance, and developing alternate labeling condi-
tions.4-8 However, most of these reports have conducted
most of the chemistry in a “manual” format, wherein a
stock solution of nucleophilic [18F]fluoride is divided into
aliquots and used in multiple reactions carried out in
sealed vials or in a synthesis module.
These proof‐of‐concept studies encouraged us to auto-
mate the reaction to facilitate its use with starting radioac-
tivity required for production of clinical radiotracer doses.
Such syntheses typically utilize multiple Curies of cyclo-
tron‐produced [18F]fluoride (~1‐30 Ci or 37‐1110 GBq),
and safety requirements at these scales usually preclude
manual manipulation. Instead, for such production runs,
[18F]fluoride is purified, azeotropically dried, reacted with
the precursor, purified by semipreparative HPLC and/or
solid phase extraction, and formulated as a sterile isotonic
injectable dose, all using an automated synthesis module
housed in a commercial “hot‐cell” that provides adequate
shielding and containment. Safety and current good
manufacturing practice standards require automated
methods with data tracking, so it is of utmost importance
that any new chemistry, such as the [18F]fluorination of
organoborons, be validated according to the pertinent reg-
ulations (eg, 21CFR212 in the United States) prior to syn-
thesizing clinical doses.9 Adapting a manual method for
automation can present several challenges including dif-
ferences in the presence/absence of atmospheric air and/
or water (eg, automated synthesis module reactors are
usually under an inert atmosphere, while manual reac-
tions on the bench are often performed under ambient
atmosphere); [18F]fluoride source including the fluoride
processing reagents like K2CO3 or, in our case, KOTf (as
stated above, automated reactions frequently require
larger amounts of such reagents); the total activity of
[18F]fluoride used (typically automated reactions employ
Ci amounts, while manual reactions employ mCi or μCi
amounts), and the presence of leftover reactants and/or
reaction byproducts that need to be removed during puri-
fication of the PET radiotracer. All of these issues can
potentially lead to significant differences in observed
manual RCC and the isolated radiochemical yield (RCY)
achieved upon automation. For example, in our initial
efforts to automate our radiofluorination of boronic acids
and pinacol boronate esters, two complicating factors
were quickly identified: (A) we noted a reduction in
RCC when azeotropically dried fluoride was used insteadof the [18F]fluoride stock solution used in manual reac-
tions, and (B) we observed the formation of a protoarene
impurity (formed via protodeboronation) that often
coeluted with the [18F]fluoroarene and thus complicated
HPLC purification of radiotracers. This paper reports
our efforts to address these two issues and thereby enable
the routine automated production of clinical radiotracer
doses by using our previously published Cu‐mediated
radiofluorination of arylborons. Proof‐of‐concept is dem-
onstrated through the synthesis of [18F]‐(±)‐IPMICF17
(2‐F), a radiolabeled inhibitor of tropomyosin receptor
kinase B/C (TrkB/C) that is currently being developed
for PET imaging of TrkB/C.10,112 | EXPERIMENTAL
Full details of (radio)synthesis procedures and quality
control methods, as well as all associated analytical data,
can be found in the Supporting Information.2.1 | General radiofluorination details
Fluorine‐18 was produced via the 18O(p,n)18F nuclear
reaction by using a GE PETTrace cyclotron. The [18F]fluo-
ride was then processed and either employed in manual
reactions or automated syntheses by using a TRACERLab
FXFN radiochemistry synthesis module, according to the
methods described in the Supporting Information. Total
recovered activity at the end‐of‐synthesis was measured
with a Capintec dose calibrator.2.2 | Quality control analysis
Radiochemical reactions were analyzed by radio‐TLC
and/or HPLC by using a Bioscan AR‐2000 TLC scanner
or Shimadzu LC‐2010A HT system equipped with a
Bioscan B‐FC‐1000 radiation detector, respectively,
according to the methods described in the Supporting
Information.3 | RESULTS AND DISCUSSION
The general decrease (and unpredictability) in RCC, when
copper‐mediated fluorodeborylation is automated in a
synthesis module, along with the formation of the
protoarene side product, was first noted in our earlier
report.2 While we note that several groups have since used
this chemistry as‐is to produce a number of different
radiotracers,12-15 we nevertheless felt that these two issues
left opportunities for improvement. As such, we have
focused upon optimizing the chemistry for routine use
230 MOSSINE ET AL.in the automated production of doses in high yield, purity,
and specific activity.
The primary differences between reactions conducted
manually in vials using batch‐produced [18F]fluoride
versus those within an automated synthesis module are
(A) the general absence of atmospheric air in a synthesis
module due to the use of argon or helium push gas and
(B) the reaction in a synthesis module that starts off with
cyclotron‐produced [18F]fluoride that is dried alongside a
significant amount of eluent salt (typically K2CO3 and,
in our case, KOTf), which is not dissolved prior to addi-
tion of solutions of reactants and reagents. The need for
atmospheric air (dioxygen) in our method was ruled out
in our prior report2 and thus could not account for the dif-
ference in reactivity between manual and automated reac-
tions. Thus, we hypothesized that problems were
originating from differences in [18F]fluoride preparation
between manual and automated processes.
The high concentration of quaternary
methylammonium (QMA) eluent salt represents one pos-
sible origin of the lower yields. During an automated run,
5 mg of KOTf is present, and this represents only ~1/50th
of that present during a typical manual reaction. To test
for this possibility, we conducted manual reactions run
with concurrent addition of 5 mg KOTf. However, as
shown in Supporting Information S3.3.3, pg S10, the
RCCs were nearly identical (74% vs 75% for 1B(OH)2;
75% vs 78% for 1Bpin). Therefore, the form of the [18F]
fluoride reagent in the reaction ([18F]KF) was implicated.
In considering the reaction further, we hypothesized that
the only way product formation could be significantly
impacted by the use of dry [18F]fluoride instead of dis-
















Time (minutes)occurred more slowly than the conversion of the
arylboron precursor into nonfluorinated byproducts. To
investigate this, a time study was conducted, wherein
manual reactions in vials were heated and removed at
various time points during the 20‐minute reaction time.
The synthesis of [18F]4‐acetophenone ([18F]FAP, 1‐F)
from 4B(OH)2‐acetophenone (1‐B(OH)2) or 4Bpin‐
acetophenone (1‐Bpin) was used as the test reaction in
this study for consistency with our earlier reports.2,4 In
addition to RCC to 1‐F, concurrent HPLC analysis was
also conducted to identify and quantify the byproducts
formed (protoarene (1‐H) and phenol (1‐OH) impurities,
Scheme 1). This experiment showed that when using 1‐
B(OH)2, most of radiofluorination occurred within the
first 5 minutes, with only a modest increase in RCC
between 5 and 10 minutes, and even less between 10
and 20 minutes (Figure 1 and Supporting Information
S.3.3.1, pg S6). Furthermore, the amount of precursor
quickly decreased, while the proportion of both impurities
increased (Figure 2). Both the rapid increase in RCC and
consumption of starting material were less pronounced
with 1Bpin (Figures 1 and 3).
To determine whether the consumption of precursor 1‐
B(OH)2 prior to the dissolution of [
18F]KF could adversely
affect RCC to the degree observed upon automation, all of
the reactants except for [18F]fluoride were heated at 110°C
for 20 minutes. The [18F]fluoride stock was then added to
the solution, and the reaction was reheated for 20 minutes
at 110°C. This showed a very pronounced decrease in RCC
versus the control fluorination (1% vs 73%). As with the
time course experiment, the effect was less pronounced
for 1‐Bpin, with a much smaller decrease in RCC versus





FIGURE 1 Radiochemical conversion
(RCC) over time for radiofluorination of 1‐
B(OH)2 and 1‐Bpin
FIGURE 3 Substrate consumption and




















FIGURE 2 Substrate consumption and





















MOSSINE ET AL. 231reactions could indeed be limiting the RCC of the [18F]
fluorination if they occur prior to addition of [18F]fluoride
to the reaction (or in the case of automated synthesis, prior
to dissolution of azeotropically dried [18F]fluoride). Based
on these findings, a possible solution to the problem of
diminished RCC was to improve the solubility of the
azeotropically dried [18F]KF. Interestingly, prior efforts to
improve the solubility of [18F]KF in these types of reactions
by using phase transfer catalysts such as kryptofix 2.2.2 or
18‐crown‐6 have been largely ineffective, providing prod-
ucts in the same (or even diminished) RCCs when they
are included. We therefore considered predissolving the
azeotropically dried [18F]KF prior to addition of the
remaining reactants or, alternately, identifying a more sol-
uble form of [18F]fluoride.
A series of reactions were conducted where [18F]KF
was premixed with various reactants, heated for
20 minutes at 110°C, and then mixed with any remaining
reactants and reheated for an additional 20 minutes
(Table 1, Entries 1‐8). In a parallel study, various combi-
nations of reagents were premixed and heated for
20 minutes, followed by the addition of [18F]KF and any
remaining reagents/reactants for a second round of
heating (Table 1, Entries 9‐16). The 2 studies simulated
the results of an automated predissolution step in the
presence/absence of different reagents/reactants.
The results of these order of addition studies were
similar to those for a variation of this reaction that we
recently reported4 and are summarized in Table 1. Thedata demonstrate the importance of addition order due
to the dissolution of dried [18F]KF in the automated reac-
tion method. The highest RCCs for both substrates were
obtained by mixing everything together well (Entry 1).
Premixing [18F]KF with precursor + pyridine (Entry 3),
precursor and Cu(OTf)2 (Entry 4), and either precursor
(Entry 6) or pyridine (Entry 7) alone, followed by the
addition of the remaining reagents, also provided reason-
able RCCs. The other permutations had variable degrees
of success and appeared to be substrate‐dependent. For
example, premixing [18F]KF in neat DMF without other
reactants worked well for 1‐B(OH)2, but this protocol sup-
pressed the yield with 1‐Bpin (Entry 8), and this was also
the case with Cu(OTf)2 + pyridine premixing (Entry 12).
Interestingly, the control reactions, where reactants were
premixed at 110°C followed by the addition of [18F]KF
and remaining reagents/reactants, also gave some valu-
able insight into this transformation. Preheating Cu(OTf)2
with either of the substrates and with (Entry 2) or without
(Entry 10) [18F]KF led to significantly suppressed yields,
suggesting that the role of pyridine may be to counteract
deleterious side reactions in addition to acting as a ligand
for Cu(OTf)2.
These data served as a roadmap for automation.
Several successful premixing procedures were carried
out for the synthesis of 1‐F from1‐B(OH)2 and 1‐Bpin
(Table 2). The crude (unpurified) reaction mixture was
analyzed by radio‐TLC and radio‐HPLC to determine



















































































































































































































































































































































































232 MOSSINE ET AL.
TABLE 2 Automated syntheses of 1‐F
Entry Substrate Quaternary Methylammonium (QMA) Eluent Fluoride Predissolution Medium RCC n
1 1‐B(OH)2 KOTf/K2CO3 No dissolution step 10 ± 2%
a 2
2 1‐B(OH)2 KOTf/K2CO3 DMF 43 ± 0% 3
3 1‐B(OH)2 KOTf/K2CO3 Substrate 30 ± 8% 2
4 1‐B(OH)2 KOTf/K2CO3 Substrate + pyridine 39 ± 7% 2
5 1‐Bpin KOTf/K2CO3 DMF 32 ± 24% 2
6 1‐Bpin KOTf/K2CO3 Substrate 56 ± 4% 2
7 1‐Bpin KOTf/K2CO3 Substrate + pyridine 53 ± 12% 2
8 1‐B(OH)2 Triethylamine No dissolution step 34 ± 7% 2
9 1‐B(OH)2 Triethylamine DMF 19 ± 6% 2
10 1‐B(OH)2 Triethylamine Substrate 23 ± 9% 2
11 1‐B(OH)2 Triethylamine Substrate + pyridine 21 ± 2% 2
aOriginal conditions reported in Mossine et al.2
MOSSINE ET AL. 233RCC as well as total activity values). All reactions were
conducted with ~150‐mCi starting activity (cyclotron‐pro-
duced target water from a 2 minute beam), and our previ-
ously reported data (without a predissolution step2) were
used as a basis of comparison after appropriate scaling
(Table 2, Entry 1). As expected, all variants fared better
than the previously reported automated results with no
premixing. Furthermore, the automated RCC values
started to approach the manual RCC values for fluorina-
tion of both 1‐B(OH)2 (Table 2, Entries 2‐4) and 1‐Bpin
(Table 2, Entries 5‐7). Interestingly, there were differences
in the automated fluorination of 1‐B(OH)2 versus the
fluorination of 1‐Bpin, and these closely followed the
results from the order of addition study. For example,
with 1‐B(OH)2, the best automation result occurred when
[18F]KF was predissolved in DMF (Table 2, Entry 2). In
contrast, with 1‐Bpin, predissolution in DMF (Table 2,
Entry 5) was worse than predissolution in either precur-
sor/DMF (Table 2, Entry 6) or precursor/pyridine/DMF
(Table 2, Entry 7). This indicates that optimal conditions
are different when boronic acid and Bpin precursors are
utilized, and the experimental protocol should be modi-
fied accordingly.The use of a more soluble form of [18F]fluoride is an
alternate strategy to address the dissolution of [18F]fluo-
ride in DMF. Toward this end, we recently showed that
weak nitrogenous bases can be used to elute [18F]fluoride
from QMA Sep‐Paks to prepare more soluble forms
of [18F]fluoride.4 Specifically, we utilized 0.1 M aq
triethylamine as an eluent in this chemistry, as the subse-
quent form of [18F]fluoride was expected to be organic‐
soluble [18F]triethylamine hydrofluoride ([18F]TEAHF).
Although triethylamine was previously reported to hinder
radiofluorination in this reaction,2 we posited that any
residual triethylamine would evaporate during azeotropic
drying, leaving only the [18F]TEAHF salt in the reactor.
Because such a salt is expected to be much more readily
soluble than [18F]KF in organic media, we anticipated
that the order of addition would have little impact on
reaction yields. This was observed to be the case. For
example, 34 ± 7% RCC to 1‐F was observed when the
automated reaction was conducted with triethylamine
eluent without a separate [18F]fluoride dissolution step
(Table 2, Entry 8). In fact, lower RCCs were observed
when various predissolution steps were implemented
with this eluent (Table 2, Entries 9‐11), and the 1‐F
234 MOSSINE ET AL.activity is over 50% greater when this step is eliminated
from the reaction protocol. A generally slightly lower
RCC with [18F]TEAHF/TEA versus [18F]KF/KOTf auto-
mated reactions was somewhat surprising but may be
due to the acidity of [18F]TEAHF or residual
triethylamine if it were not completely removed during
azeotropic drying. As such, we conducted further optimi-
zation studies by using the KOTf/K2CO3 eluent.
To challenge the chemistry further, the optimized
[18F]KF dissolution/order of addition with KOTf/K2CO3
eluent was applied to the synthesis of [18F]‐(±)‐IPMICF17
(2‐F), a PET radiotracer for TrkB/C that is currently being
developed by the Schirrmacher and Scott groups
(Scheme 2).10,11 We expected this molecule to be amena-
ble to such labeling because it has been previously dem-
onstrated that the 6‐(pyrrolidin‐1‐yl)imidazo[1,2‐b]
pyridazine core does not inhibit Cu‐mediated fluorination
reactions.6 Synthesis from the (±)‐IPMICF17 Bpin precur-
sor (2‐Bpin) was carried out both manually and in an
automated format, with predissolution of [18F]KF per-
formed with a precursor/DMF solution. Manual reactions
afforded an RCC of 43 ± 5% (see Supporting Information
S4.5, pg S22). Analysis of the crude mixture from an auto-
mated test reaction in a synthesis module showed 25%
RCC to product 2‐F, when starting from ~150 mCi of
[18F]fluoride. Fully automated synthesis, semipreparative
HPLC purification, and reformulation in sterile saline
led to an isolated RCY of 4.1 ± 0.2% (61 ± 4 mCi from a
starting activity of ~1500 mCi/ 30‐min beam, nondecay
corrected, n = 2), which is suitable for ongoing preclinical
and clinical studies.
Although an acceptable RCY was obtained in the syn-
thesis of [18F]‐(±)‐IPMICF17 (2‐F), the large size and
complexity of this molecule did not allow for the separa-
tion of 2‐F from the protoarene impurity (2‐H) via stan-
dard C18 semipreparative HPLC (see Supporting
Information S.4.5.2, pg S25‐S27, for HPLC spectra). This
impurity is present at a significantly higher mol% than
the radiofluorinated product, and it is expected to be
approximately equipotent against the same target (TrkB/
C) as the 18F‐labeled tracer. As such, the lower effective
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SCHEME 2 Radiosynthesis of [18F]‐(±)‐IPMICF17 (2‐F)expected to be detrimental to the imaging results. We
anticipate that this problem could represent a general lim-
itation of the method, particularly when dealing with
drug‐like molecules. Thus, additional optimization was
carried out to achieve separation of product 2‐F from
protoarene impurity 2‐H.
Initial efforts focused on limiting the formation of the
protoarene impurity 2‐H via chemical means. Alternate
solvents, the addition of strong and weak bases, and inclu-
sion of oxidants (eg, tBuO2) were all explored, based on a
recent report showing that these variables can reduce the
presence of the protoarene (2‐H) and phenol (2‐OH)
byproducts in related Chan‐Lam coupling reactions.16
These studies showed that the use of stronger bases did
result in a decrease in the concentration of protoarene
byproduct 2‐H. However, this was also accompanied by
a significant decrease in RCC to the desired fluorinated
product 2‐F. We therefore next turned our attention to
developing HPLC methods that would allow for the
facile separation of protoarene (2‐H) from [18F]‐(±)‐
IPMICF17 (2‐F).
In prior reports, we have utilized HPLC columns
with pentafluorophenyl (PFP) stationary phases to sepa-
rate polyfluorinated materials such as [18F]N‐methyl
lansoprazole and its precursor17 and, more recently,
[18F]fluoroarene products from protoarene starting mate-
rials in CH‐activation chemistry.18 Building on this
work, we reasoned that an appropriately optimized elu-
ent system with a PFP semipreparative column would
allow for the separation of [18F]‐(±)‐IPMICF17 (2‐F)
from its protoarene byproduct (2‐H). For initial optimi-
zation efforts, a crude [18F]‐(±)‐IPMICF17
radiofluorination reaction mixture spiked with [19F]‐
(±)‐IPMICF17 reference standard was eluted with a
range of NH4OAc‐buffered H2O/MeCN eluents on a
Luna‐PFP analytical column. This allowed us to take
into account all of the impurities present in the reaction
when optimizing HPLC separation, including protoarene
2‐H. While peak overlap was still observed at higher
%MeCN eluents, lower %MeCN eluents showed separa-
tion of the fluoroarene and protoarene peaks (see
Supporting Information S.4.5.1, pg S23). The eluent was
further optimized with a Kinetex PFP semipreparative
column, and an eluent consisting of 45% MeCN buffered
with 10‐mM NH4OAc at pH 7.5 was found to separate
product 2‐F from impurity 2‐H in a manual
radiolabeling sample of [18F]‐(±)‐IPMICF17, with reten-
tion times of ~45 minutes for the byproduct (2‐H) and
~52 minutes for [18F]‐(±)‐IPMICF17 (2‐F). Full produc-
tion runs were then performed to determine if [18F]‐
(±)‐IPMICF17 could be isolated absent of any
protoarene byproduct at an acceptable RCY. Product
was isolated with RCY of 1.9 ± 0.1% (28 ± 2 mCi from
MOSSINE ET AL. 235a starting activity of ~1500 mCi, nondecay corrected,
n = 3), excellent radiochemical purity (>99%), and high
specific activity (5294 ± 1227 Ci/mmol), and analytical
HPLC gratifyingly showed that no protoarene impurity
was present in the final reformulated doses. Quality con-
trol testing of [18F]‐(±)‐IPMICF17 has confirmed suit-
ability of doses for in vivo use in animal and human
imaging applications (see Supporting Information
S4.5.3, pg S27‐S30, for representative semipreparative
and analytical HPLC traces). Biodistribution and
microPET imaging studies are underway to evaluate this
radiotracer in rodents, primates, and human subjects.
The optimization studies in this report have led to
more efficient automated Cu‐mediated radiofluorination
reactions. However, it is noteworthy that the isolated
RCYs (1.9‐4.1%) of [18F]‐(±)‐IPMICF17 are still lower
than would be expected given the automated RCC
(25%). We believe that this discrepancy does not result
from the fluorination reaction but represents challenges
associated with the first efforts by our group and others
in fitting organometallic chemistry into the confines of
automated current good manufacturing practice (cGMP)
PET radiotracer production.9,19 Our efforts to develop
novel transition metal‐mediated [18F]fluorination reac-
tions, including new methods for processing [18F]fluoride
and automation of reactions, investigation of reaction
mechanisms, and exploration of substrate scope are
ongoing2,4,18,20,21 and will ensure that these new reactions
continue to be further optimized for routine PET radio-
tracer manufacture.4 | CONCLUSIONS
This report updates our recently published copper‐medi-
ated [18F]fluorodeboronation method for the automated
production of PET radiotracers suitable for clinical use.
Two recurrent problems, low RCC upon automation and
protoarene byproduct purification issues, have been
addressed. Building on our earlier report, a [18F]KF
predissolution step has been developed to increase auto-
mated RCC with KOTf QMA eluent. An alternative proce-
dure involving triethylamine as the QMA eluent is also
effective. The automated method was utilized to produce
sterile injectable doses of [18F]‐(±)‐IPMICF17 in an
automated synthesis module in reasonable isolated RCY.
Purification of [18F]‐(±)‐IPMICF17 was achieved with a
PFP semipreparative HPLC column, thereby preventing
contamination of the dose with the protoarene impurity
prevalent in this and similar transition metal‐mediated
reactions. Doses of [18F]‐(±)‐IPMICF17 prepared in this
fashion are being used in ongoing preclinical and clinical
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